Jimenez Lisy, Ruiz Nelly, Benavides Sandra, Deb Subrata, Caballero Joshua, Parmar Jayesh
Larkin University-College of Pharmacy, 18301 N. Miami Avenue, Miami, FL 33169, United States.
Department of Pharmaceutical Sciences, Larkin University-College of Pharmacy, 18301 N. Miami Avenue, Miami, FL 33169, United States.
Curr Pharm Teach Learn. 2019 Nov;11(11):1117-1122. doi: 10.1016/j.cptl.2019.07.013. Epub 2019 Aug 9.
Students consider numerous variables before applying to a doctor of pharmacy program. Some key non-modifiable variables may include program length, institution type, graduating class size, and pharmacy school grading system. The purpose of this study was to determine if there exists a difference in North American Pharmacists Licensure Examination (NAPLEX) performance based upon these variables.
This was a retrospective cohort study using observational data. NAPLEX pass rates from 2015 to 2017 were obtained from the National Association of Boards of Pharmacy (NABP) website. Data for pharmacy programs were extracted from the program, Pharmacy College Application Service, American Association of Colleges of Pharmacy, and NABP websites.
Based on each pharmacy program's performance on NAPLEX, variables with significantly higher pass rates were public institutions and those with graduating class sizes of 100 or more students.
The results of this study suggest that graduating class size of 100 or more students and public institutions were significant predictors of success on the NAPLEX. Lower pass rates in 2016 may be due to the examination changes implemented by NABP that year. It is possible that programs and students were not being adequately prepared for the changes made to the NAPLEX format. Although not statistically significant, there was a rise in pass rates between the years 2016 and 2017. Therefore, future studies such as this one should be performed to compare NAPLEX pass rates from 2017 forward.
学生在申请药学博士项目之前会考虑众多变量。一些关键的不可改变变量可能包括项目时长、机构类型、毕业班级规模以及药学院评分系统。本研究的目的是确定基于这些变量,北美药剂师执照考试(NAPLEX)的成绩是否存在差异。
这是一项使用观察性数据的回顾性队列研究。2015年至2017年的NAPLEX通过率从美国药学委员会协会(NABP)网站获取。药学项目的数据从项目、药学院申请服务中心、美国药学院协会以及NABP网站提取。
基于每个药学项目在NAPLEX上的表现,通过率显著更高的变量是公立机构以及毕业班级规模为100名或更多学生的项目。
本研究结果表明,毕业班级规模为100名或更多学生以及公立机构是NAPLEX考试成功的重要预测因素。2016年通过率较低可能是由于当年NABP实施的考试变革。项目和学生可能没有为NAPLEX形式的变化做好充分准备。尽管在统计学上不显著,但2016年至2017年通过率有所上升。因此,应该开展此类未来研究以比较2017年以后的NAPLEX通过率。